Clinical review demonstrates efficacy of low-molecular-weight heparin for preventing fatal pulmonary embolism in hospitalized patients, highlighting the need for routine prophylaxis in high-risk...
Venous thromboembolism is a frequent complication in hospitalized patients. A number of drugs are now available to prevent this complication. These include dextron, oral anticoagulants, standard heparin and low-molecular-weight heparin. The efficacy of these drugs is reviewed in this paper. The data presented indicate that a single fixed daily subcutaneous injection of low-molecular-weight heparin provides a simple and an effective method of preventing death due to massive pulmonary embolism. Therefore emphasis should now be on the physicians and surgeons to protect all high-risk patients.
No takes yet. Share an insight, caveat, or question.
V. V. Kakkar (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: